(Q35089975)

6 August 2017

1 reference

title

The menopause, hormone replacement therapy and breast cancer (English)

1 reference

Hormone Replacement Therapy

6 August 2017

main subject

1 reference

Jo Marsden

1

1 reference

6 August 2017

publication date

1 December 2002

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

6 August 2017

published in

1 reference

6 August 2017

volume

83

1 reference

6 August 2017

issue

1-5

1 reference

6 August 2017

page(s)

123-132

1 reference

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Evidence from randomised trials on the long-term effects of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Estrogen-progestin replacement therapy and endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Symptoms of oestrogen deficiency associated with supraphysiological plasma oestradiol concentrations in women with oestradiol implants

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Diethylstilbestrol: Recommended Dosages for Different Categories of Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Pharmacokinetics of oestrogens and progestogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Androgens induce divergent proliferative responses in human breast cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Serum estradiol level and risk of breast cancer during treatment with raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Cell turnover in the "resting" human breast: influence of parity, contraceptive pill, age and laterality

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Serum progesterone and prognosis in operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Oestrogen therapy after the menopause--boon or bane?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Mammographic features and breast cancer risk: effects with time, age, and menopause status.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Cytogenetic findings in invasive breast carcinomas with prognostically favourable histology: a less complex karyotypic pattern?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Hormone replacement therapy in relation to breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Hormone replacement therapy and high S phase in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Tamoxifen for breast cancer among hysterectomised women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Hormone replacement therapy and the risk of death from breast cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Results from the UK NHS breast screening programme 1994-1999

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Short-term cessation of hormone replacement therapy and improvement of mammographic specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Hormone replacement therapy and accuracy of mammographic screening

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Pre-operative oestradiol levels - relation to survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

The results of modified use of chemotherapy for patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

Stepwise estrogen suppression manipulating the estrostat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

The potential role of estrogen in aromatase regulation in the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900258-3

7 January 2021

10.1016/S0960-0760(02)00258-3

Identifiers

DOI

1 reference

6 August 2017

1 reference